論文・総説 - 原田　浩之

181. Takei J, Kaneko MK, Ohishi T, Kawada M, Harada H, Kato Y. H2Mab-19, an anti-human epidermal growth factor receptor 2 monoclonal antibody exerts antitumor activity in mouse oral cancer xenografts Exp Ther Med. 2020.04; 20 (2): 846-853. ( PubMed, DOI )

182. Kato Y, Ito Y, Ohishi T, Kawada M, Nakamura T, Sayama Y, Sano M, Asano T, Yanaka M, Okamoto S, Handa S, Komatsu Y, Takei J, Kaneko MK. Antibody–drug conjugates using mouse–canine chimeric anti-dog podoplanin antibody exerts antitumor activity in a mouse xenograft model Monoclon Antib Immunodiagn Immunother. 2020.04; 39 (2): 37-44. ( PubMed, DOI )

183. Yamada S, Kaneko MK, Sayama Y, Asano T, Sano M, Yanaka M, Nakamura T, Okamoto S, Handa S, Komatsu Y, Nakamura Y, Furusawa Y, Takei J, Kato Y. Development of novel mouse monoclonal antibodies against human CD19 Monoclon Antib Immunodiagn Immunother. 2020.04; 39 (2): 45-50. ( PubMed, DOI )

184. Takei J, Kaneko MK, Ohishi T, Kawada M, Harada H, Kato Y. A novel anti-EGFR monoclonal antibody (EMab-17) exerts antitumor activity against oral squamous cell carcinomas via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity Oncol Lett. 2020.04; 19 (4): 2809-2816. ( PubMed, DOI )

185. Ohsako T, Shimamoto H, Tomioka H, Hirai H, Kuroshima T, Mochizuki Y, Kugimoto T, Tsushima F, Nakamura S, Kurabayashi T, Harada H. Detection of extraoral primary cancers by positron emission tomography/computed tomography in patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020.03; 129 (3): 272-276. ( PubMed, DOI )

186. Yokokawa M, Morita KI, Oikawa Y, Kayamori K, Sakamoto K, Ikeda T, Harada H. Co‐expression of EGFR and MET has a synergistic effect on the prognosis of patients with oral squamous cell carcinoma J Oral Pathol Med. 2020.03; 49 (3): 235-242. ( PubMed, DOI )

187. Yahara H, Horita S, Yanamoto S, Kitagawa Y, Asaka T, Yoda T, Morita K, Michi Y, Takechi M, Shimasue H, Maruoka Y, Kondo E, Kusukawa J, Tsujiguchi H, Sato T, Kannon T, Nakamura H, Tajima A, Hosomichi K, Yahara K. A Targeted Genetic Association Study of the Rare Type of Osteomyelitis J Dent Res. 2020.03; 99 (3): 271-276. ( PubMed, DOI )

188. Yamamoto D, Kayamori K, Sakamoto K, Tsuchiya M, Ikeda T, Harada H, Yoda T, Watabe T, Hara-Yokoyama M. Intracellular claudin-1 at the invasive front of tongue squamous cell carcinoma is associated with lymph node metastasis Cancer Sci. 2020.02; 111 (2): 700-712. ( PubMed, DOI )

189. Nguyen CTK, Sawangarun W, Mandasari K, Morita KI, Harada H, Kayamori K, Yamaguchi A, Sakamoto K. AIRE is induced in oral squamous cell carcinoma and promotes cancer gene expression PLoS ONE. 2020.02; 15 (2): e0222689. ( PubMed, DOI )

190. Yukimori A, Tsuchiya M, Wada A, Michi Y, Kayamori K, Sakamoto K, Ikeda T. Genetic and histopathological analysis of a case of primary intraosseous carcinoma, NOS with features of both ameloblastic carcinoma and squamous cell carcinoma World J Surg Oncol. 2020.02; 18 (1): 45. ( PubMed, DOI )

191. Yamamoto Daisuke, Kayamori Kou, Sakamoto Kei, Tsuchiya Maiko, Ikeda Tohru, Harada Hiroyuki, Yoda Tetsuya, Watabe Tetsuro, Hara-Yokoyama Miki. 舌扁平上皮癌の浸潤先端部にみられる細胞内のクローディン1はリンパ節転移と関連している(Intracellular claudin-1 at the invasive front of tongue squamous cell carcinoma is associated with lymph node metastasis) Cancer Science. 2020.02; 111 (2): 700-712. ( 医中誌 )

192. Nojima H, Homma H, Onozato Y, Kaida A, Harada H, Miura M. Differential properties of mitosis-associated events following CHK1 and WEE1 inhibitor treatments in human tongue carcinoma cells Exp Cell Res. 2020.01; 388 (2): 111720. ( PubMed, DOI )

193. Kagifuku Y, Tohara H, Wakasugi Y, Susa C, Nakane A, Toyoshima M, Nakakuki K, Kabasawa Y, Harada H, Minakuchi S. What Factors Affect Changes in Body Composition and Swallowing Function in Patients Hospitalized for Oral Cancer Surgery? Clin Interv Aging. 2020.01; 15 1-7. ( PubMed, DOI )

194. Homma H, Nojima H, Kaida A, Miura M. Induction of endomitosis-like event in HeLa cells following CHK1 inhibitor treatment Biochem Biophys Res Commun. . 2019.12;

195. Oikawa Y, Michi Y, Tsushima F, Tomioka H, Mochizuki Y, Kugimoto T, Osako T, Nojima H, Yokokawa M, Kashima Y, Harada H. Management of retropharyngeal lymph node metastasis in oral cancer. Oral Oncology. 2019.12; 99 104471. ( PubMed, DOI )

196. Kato Y, Takei J, Furusawa Y, Sayama Y, Sano M, Konnai S, Kobayashi A, Harada H, Takahashi M, Suzuki H, Yamada S, Kaneko MK. Epitope Mapping of Anti-Bear Podoplanin Monoclonal Antibody PMab-247. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.10; 38 (5): 230-233. ( PubMed, DOI )

197. Takei J, Itai S, Harada H, Furusawa Y, Miwa T, Fukui M, Nakamura T, Sano M, Sayama Y, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Yamada S, Kaneko MK, Kato Y. Characterization of Anti-Goat Podoplanin Monoclonal Antibody PMab-235 Using Immunohistochemistry Against Goat Tissues. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.10; 38 (5): 213-219. ( PubMed, DOI )

198. Kojima Y, Kawaoka Y, Sawada S, Hayashida S, Okuyama K, Yutori H, Kawakita A, Ishida S, Soutome S, Yanamoto S, Umeda M, Iwai H.. Clinical significance of periosteal reaction as a predictive factor for treatment outcome of medication-related osteonecrosis of the jaw. Journal of Bone and Mineral Metabolism. 2019.09; 37 (5): 913-919. ( PubMed, DOI )

199. Nakazato K, Mogushi K, Kayamori K, Tsuchiya M, Takahashi KI, Sumino J, Michi Y, Yoda T, Uzawa N. Glucose metabolism changes during the development and progression of oral tongue squamous cell carcinomas. Oncol Lett. 2019.08; 8 (2): 1372-1380.

200. Takei J, Furusawa Y, Yamada S, Nakamura T, Sayama Y, Sano M, Konnai S, Kobayashi A, Harada H, Kaneko MK, Kato Y. PMab-247 Detects Bear Podoplanin in Immunohistochemical Analysis. Monoclon Antib Immunodiagn Immunother.. 2019.08; 38 (4): 171-174.